Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Centella Asiatica extract - Oneness Biotech

Next Previous
Drug Profile

Centella Asiatica extract - Oneness Biotech

Alternative Names: COMPLEHEAL™; DCB WH1; Fespixon; Fespixon® cream; ON-101; ONENESS™; PA-F4; Plectranthus amboinicus extract - Oneness Biotech; S1; WH 1

Latest Information Update: 07 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Development Center for Biotechnology
  • Developer HaiHe Biopharma; Oneness Biotech
  • Class Flavanones; Foot disorder therapies; Herbal medicines; Terpenes
  • Mechanism of Action Macrophage modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Diabetic foot ulcer

Highest Development Phases

  • Marketed Diabetic foot ulcer

Most Recent Events

  • 02 Oct 2023 Updated efficacy data from the phase III MRCT trial in Diabetic foot ulcer presented at the 59th Annual Meeting of the European Association for the Study of Diabetes (EASD-2021)
  • 31 Jan 2023 Registered for Diabetic foot ulcer in Singapore (Topical)
  • 09 Jan 2023 Launched for Diabetic foot ulcer in Macau (Topical), prior to January 2023 (Oneness Biotech Pipeline, January 2023)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top